Stem cell infusion for Crohn’s or ulcerative colitis safety
Treatments studied
Part of Digestive system clinical trials.
This Phase 1 trial tests whether an IV infusion of donated (allogeneic) stem cells is safe in people with Crohn’s disease or ulcerative colitis. It focuses mainly on safety and tolerability, and it may offer a new treatment approach if you qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Crohn’s disease or ulcerative colitis
- You are willing to read and sign a written informed consent form
- You do not have an active infection at the time of study entry
- You do not have active cancer and you do not have serious long-term organ failure
- You are not pregnant, and if you could become pregnant you use effective birth control
- You have no major concerning lab test results and no safety risk your study doctor identifies
- You have not had an organ transplant and you do not have a known allergy to sulfur
- You are not currently in ongoing drug abuse
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests how safe an intravenous (through a vein) stem cell product is for people with rheumatoid arthritis. It is mainly looking for side effects and safety rather than proving it works yet.
This Phase 1 study tests whether an IV infusion of stem cells from donated umbilical cord tissue is safe for people with idiopathic pulmonary fibrosis. It focuses mainly on safety and tolerability, and it may help by offering a new treatment approach if the cells are safe for you.
This early-phase study tests whether lab-made stem cells from donated umbilical cord tissue are safe for treating a skin ulcer. It mainly looks at side effects and whether the treatment can be given safely.
This early study (Phase 1) tests whether an intravenously given, donated stem cell product is safe for people with chronic kidney disease. It mainly looks at side effects and whether the treatment can be given without harming you.
This early study (Phase 1) checks whether an infused stem cell product made from donated umbilical cord tissue is safe in people with osteoarthritis. It’s mainly looking for side effects and whether the treatment can be given safely.
This early-phase study tests whether an intravenous (through a vein) stem cell treatment made from donated umbilical cord tissue is safe for people with lupus. It focuses mainly on side effects and how well participants tolerate the infusion.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.